The Latin America, Middle East and Africa Exosome Diagnostic and Therapeutic Market would witness market growth of 28.8% CAGR during the forecast period (2022-2028).
Exosomes have the potential to be a drug delivery vehicle because they have natural material transportation properties, the ability to support intrinsic long-term circulation, and high biocompatibility, all of which are ideal for the delivery of a wide range of proteins, chemicals, and nucleic acids. Exosomes have shown to be effective as intercellular communication mediators in a few studies, potentially conveying functional proteins, mRNA transcripts, and miRNAs to cells all over the body. Exosomes, which are formed from certain types of cells (such as dendritic and mesenchymal stem cells), have potential therapeutic qualities and are biocompatible and effective agents against a wide range of diseases, including organ injury and diseases of the heart, kidney, liver, and lungs.
Infectious and chronic diseases afflict Africa in equal measure. While infectious diseases continue to account for at least 69 percent of deaths on the continent, chronic disease mortality rates are significantly greater in Sub-Saharan Africa than in practically every other region of the world, for both men and women. The continent is expected to see the greatest increase in death rates from cardiovascular illness, cancer, respiratory disease, and diabetes over the next ten years. Infectious and parasitic diseases continue to get priority in government spending on healthcare training and service delivery in Africa.
In fact, in adults, total age-specific mortality rates from chronic diseases are greater than in other high-income countries, typically several times higher in younger adult age groups. Perhaps even more unexpected, existing statistics imply that overall death rates from chronic diseases are greater in Sub-Saharan Africa than in practically every other region of the world, for both men and women.
The Brazil market dominated the LAMEA Exosome Diagnostic and Therapeutic Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $21.7 million by 2028. The Argentina market is poised to grow at a CAGR of 29.5% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 28.5% during (2022 - 2028).
Based on Application, the market is segmented into Diagnostic and Therapeutic. Based on Product, the market is segmented into Reagent, Instrument, and Software. Based on End User, the market is segmented into Cancer Institute, Hospital, Diagnostic Center, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Exosome Diagnostic and Therapeutic Market is Predict to reach $1.4 Billion by 2028, at a CAGR of 26.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Qiagen N.V., Thermo Fisher Scientific, Inc., Aethlon Medical, Inc., Capricor Therapeutics, Inc., Malvern Panalytical Ltd., NanoSomix, Inc., System Biosciences, LLC, and NX Pharmagen, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
By Product
- Reagent
- Instrument
- Software
By End User
- Cancer Institute
- Hospital
- Diagnostic Center
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Bio-Techne Corporation
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
- Aethlon Medical, Inc.
- Capricor Therapeutics, Inc.
- Malvern Panalytical Ltd.
- NanoSomix, Inc.
- System Biosciences, LLC
- NX Pharmagen, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Exosome Diagnostic and Therapeutic Market, by Application
1.4.2 LAMEA Exosome Diagnostic and Therapeutic Market, by Product
1.4.3 LAMEA Exosome Diagnostic and Therapeutic Market, by End User
1.4.4 LAMEA Exosome Diagnostic and Therapeutic Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Exosome Diagnostic and Therapeutic Market
Chapter 4. LAMEA Exosome Diagnostic and Therapeutic Market by Application
4.1 LAMEA Diagnostic Market by Country
4.2 LAMEA Therapeutic Market by Country
Chapter 5. LAMEA Exosome Diagnostic and Therapeutic Market by Product
5.1 LAMEA Reagent Market by Country
5.2 LAMEA Instrument Market by Country
5.3 LAMEA Software Market by Country
Chapter 6. LAMEA Exosome Diagnostic and Therapeutic Market by End User
6.1 LAMEA Cancer Institute Market by Country
6.2 LAMEA Hospital Market by Country
6.3 LAMEA Diagnostic Center Market by Country
6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Exosome Diagnostic and Therapeutic Market by Country
7.1 Brazil Exosome Diagnostic and Therapeutic Market
7.1.1 Brazil Exosome Diagnostic and Therapeutic Market by Application
7.1.2 Brazil Exosome Diagnostic and Therapeutic Market by Product
7.1.3 Brazil Exosome Diagnostic and Therapeutic Market by End User
7.2 Argentina Exosome Diagnostic and Therapeutic Market
7.2.1 Argentina Exosome Diagnostic and Therapeutic Market by Application
7.2.2 Argentina Exosome Diagnostic and Therapeutic Market by Product
7.2.3 Argentina Exosome Diagnostic and Therapeutic Market by End User
7.3 UAE Exosome Diagnostic and Therapeutic Market
7.3.1 UAE Exosome Diagnostic and Therapeutic Market by Application
7.3.2 UAE Exosome Diagnostic and Therapeutic Market by Product
7.3.3 UAE Exosome Diagnostic and Therapeutic Market by End User
7.4 Saudi Arabia Exosome Diagnostic and Therapeutic Market
7.4.1 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Application
7.4.2 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Product
7.4.3 Saudi Arabia Exosome Diagnostic and Therapeutic Market by End User
7.5 South Africa Exosome Diagnostic and Therapeutic Market
7.5.1 South Africa Exosome Diagnostic and Therapeutic Market by Application
7.5.2 South Africa Exosome Diagnostic and Therapeutic Market by Product
7.5.3 South Africa Exosome Diagnostic and Therapeutic Market by End User
7.6 Nigeria Exosome Diagnostic and Therapeutic Market
7.6.1 Nigeria Exosome Diagnostic and Therapeutic Market by Application
7.6.2 Nigeria Exosome Diagnostic and Therapeutic Market by Product
7.6.3 Nigeria Exosome Diagnostic and Therapeutic Market by End User
7.7 Rest of LAMEA Exosome Diagnostic and Therapeutic Market
7.7.1 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Application
7.7.2 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Product
7.7.3 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by End User
Chapter 8. Company Profiles
8.1 Bio-Techne Corporation (Exosome Diagnostic, Inc.)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.2 Qiagen N.V.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.4 Aethlon Medical, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Research & Development Expenses
8.5 Capricor Therapeutics, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.6 Malvern Panalytical Ltd. (Spectris plc)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.7 Nanosomix, Inc.
8.7.1 Company Overview
8.8 System Biosciences, LLC
8.8.1 Company Overview
8.9 NX Pharmagen, Inc. (NX Prenatal, Inc.)
8.9.1 Company Overview
TABLE 1 LAMEA Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 4 LAMEA Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 5 LAMEA Diagnostic Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Diagnostic Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 10 LAMEA Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 11 LAMEA Reagent Market by Country, 2018 - 2021, USD Million
TABLE 12 LAMEA Reagent Market by Country, 2022 - 2028, USD Million
TABLE 13 LAMEA Instrument Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Instrument Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Software Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Software Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 18 LAMEA Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 19 LAMEA Cancer Institute Market by Country, 2018 - 2021, USD Million
TABLE 20 LAMEA Cancer Institute Market by Country, 2022 - 2028, USD Million
TABLE 21 LAMEA Hospital Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Hospital Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Diagnostic Center Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Diagnostic Center Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Exosome Diagnostic and Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Exosome Diagnostic and Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 29 Brazil Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 30 Brazil Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 31 Brazil Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 32 Brazil Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 33 Brazil Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 34 Brazil Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 35 Brazil Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 36 Brazil Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 37 Argentina Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 38 Argentina Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 39 Argentina Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 40 Argentina Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 41 Argentina Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 42 Argentina Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 43 Argentina Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 44 Argentina Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 45 UAE Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 46 UAE Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 47 UAE Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 48 UAE Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 49 UAE Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 50 UAE Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 51 UAE Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 52 UAE Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 53 Saudi Arabia Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 54 Saudi Arabia Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 55 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 56 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 57 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 58 Saudi Arabia Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 59 Saudi Arabia Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 60 Saudi Arabia Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 61 South Africa Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 62 South Africa Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 63 South Africa Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 64 South Africa Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 65 South Africa Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 66 South Africa Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 67 South Africa Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 68 South Africa Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 69 Nigeria Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 70 Nigeria Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 71 Nigeria Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 72 Nigeria Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 73 Nigeria Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 74 Nigeria Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 75 Nigeria Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 76 Nigeria Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 77 Rest of LAMEA Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
TABLE 78 Rest of LAMEA Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
TABLE 79 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
TABLE 80 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
TABLE 81 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
TABLE 82 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
TABLE 83 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
TABLE 84 Rest of LAMEA Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
TABLE 85 key information – Bio-Techne Corporation
TABLE 86 Key Information – Qiagen N.V.
TABLE 87 Key Information – Thermo Fisher Scientific, Inc.
TABLE 88 Key Information – Aethlon Medical, Inc.
TABLE 89 Key Information – Capricor Therapeutics, Inc.
TABLE 90 Key Information – Malvern Panalytical Ltd
TABLE 91 Key Information – Nanosomix, Inc.
TABLE 92 Key Information – System Biosciences, LLC
TABLE 93 Key Information – NX Pharmagen, Inc.
List of Figures
FIG 1 Methodology for the research